Should we, can we, halt the rise in prescribing for pain and distress?

Richard Byng*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

INTRODUCTION. Awareness of prescribed opioid dependence is now reaching the general population along with concerns about levels of antidepressant prescribing and the potential for withdrawal symptoms. Gabapentinoids have become controlled drugs and Public Health England have published their report on prescribed drugs and dependence detailing extensive long-term prescribing. Family doctors will not have failed to notice both the increasing numbers of patients being prescribed multiple drugs for pain and distress, and the change in tone in consultations as we start to worry about their effects and wonder whether adding more, or another, or just switching drugs is the right action. What is the nature of the problem? What can we do instead?
Original languageEnglish
Pages (from-to)432-433
Number of pages0
JournalBritish Journal of General Practice
Volume70
Issue number698
Early online date27 Aug 2020
DOIs
Publication statusPublished - Sept 2020

Fingerprint

Dive into the research topics of 'Should we, can we, halt the rise in prescribing for pain and distress?'. Together they form a unique fingerprint.

Cite this